350
Participants
Start Date
December 15, 2017
Primary Completion Date
December 6, 2022
Study Completion Date
December 6, 2022
WATCHMAN
WATCHMAN Device is composed of a self-expanding nitinol structure with a porous membrane on the proximal face. The implant device is delivered to the Left Atrial Appendage by femoral venous access and transseptal puncture to enter the left atrium.
TAVR
Transcatheter Aortic Valve Replacement
Columbia University Medical Center, New York
University at Buffalo, Buffalo
Pinnacle Health, Wormleysburg
WellSpan York Hospital, York
Medstar Washington Hospital Center, Washington D.C.
Inova Fairfax Hospital, Falls Church
Lexington Cardiology, West Columbia
Baptist Health Jacksonville, Jacksonville
Tallahassee Research Institute, Tallahassee
Northside Hospital, St. Petersburg
The Ohio State University, Columbus
OhioHealth Research Institute, Columbus
The Cleveland Clinic, Cleveland
St. Vincent Heart Center, Indianapolis
Parkview Research Center, Fort Wayne
Henry Ford Hospital, Detroit
Ascension St. John Hospital, Detroit
University of Iowa Hospitals and Clinics, Iowa City
Aspirus Research Institute, Wausau
Prairie Cardiovascular Consultants, Springfield
Medstar Washington University, St Louis
CHI Health Research Center, Omaha
INTEGRIS Baptist Medical Center, Oklahoma City
Heart Hospital Baylor Plano, Plano
Austin Heart, Austin
UCHealth Medical Center of the Rockies, Loveland
Intermountain Medical Center, Murray
Banner University Medical Center, Phoenix
Santa Barbara Cottage Hospital, Santa Barbara
Sutter Health/Palo Alto Medical Foundation, Burlingame
Massachusetts General Hospital, Boston
Morristown Medical Center, Morristown
Collaborators (1)
Boston Scientific Corporation
INDUSTRY
The Cleveland Clinic
OTHER
samir kapadia
OTHER